Elizabeth Chapin

July 21, 2020

UK Receives $3.2 Million for Traumatic Brain Injury Research

UK researchers Patrick Sullivan and Brad Hubbard have been awarded $3.2 million to continue research that could pave the way for a treatment for traumatic brain injury. Pete Comparoni | UK Photo.
July 16, 2020

UK Human Research Protection Program Receives Full AAHRPP Reaccreditation

UK’s Human Research Protection Program has once again been awarded full accreditation from the Association for the Accreditation of Human Research Protection Programs.
July 14, 2020

UK Study Provides New Insight on Colorectal Cancer Growth

A new study led by Markey Cancer Center researcher Qing-Bai She provides new insight on colorectal cancer growth.
July 1, 2020

UK Research Could Pave Way for Noonan-like Syndrome Treatment

University of Kentucky researcher Emilia Galperin has been awarded a $1.9 million grant to continue her research examining cell signal pathways and genetic disease. Pete Comparoni | UK Photo.
June 25, 2020

Artemisia Annua Could Be Promising Treatment for COVID-19

Artemisia Annua
June 22, 2020

UK's Korotkov Partners With Atomwise to Screen for Potential Drugs Against Novel COVID-19 Target

PLpro model
June 18, 2020

Alpacas Could be the Secret Weapon Against COVID-19

Three alpacas
June 12, 2020

CURE Alliance Uniting COVID-19 Research Across UK

UK researchers Jerry Woodward and Siva Gandhapudi have received a CURE Alliance/CCTS pilot project grant to support their research on COVID-19 antibodies. Photo by Ben Corwin, Research Communications.
May 14, 2020

UK Gets NSF Funding to Develop Face Mask that Can Deactivate COVID-19

UK engineering professor Dibakar Bhattacharyya, or "DB," directing research in his lab. With co-researchers, DB is creating a membrane-based medical face mask for COVID-19. Photo by Ben Corwin, Research Communications
May 6, 2020

UK Launches Clinical Trial to Evaluate Novel Treatments for COVID-19

COVID-19 clinical trial principal investigators Dr. Susanne Arnold, associate director of clinical translation at the UK Markey Cancer Center and Dr. Zachary Porterfield, assistant professor of Microbiology, Immunology & Molecular Genetics.

Pages